Years of painstaking basic research into the workings of the brain may now begin to bear fruit as clinical data become available for several new agents. These have been developed to prevent or reduce the damage associated with stroke, head trauma and related problems, reported researchers at the 5th International Symposium on Pharmacology of Cerebral Ischemia, held recently in Marburg, Germany.